Dimensional Fund Advisors’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13,494
| Closed | -$363K | – | 3529 |
|
|
2023
Q1 | $363K | Sell |
13,494
-6,722
| -33% | -$181K | ﹤0.01% | 3091 |
|
|
2022
Q4 | $716 | Sell |
20,216
-1,863
| -8% | -$66 | ﹤0.01% | 2978 |
|
|
2022
Q3 | $4.99M | Buy |
22,079
+4,158
| +23% | +$939K | ﹤0.01% | 2427 |
|
|
2022
Q2 | $3.39M | Buy |
17,921
+4,995
| +39% | +$944K | ﹤0.01% | 2578 |
|
|
2022
Q1 | $3.22M | Buy |
12,926
+3,405
| +36% | +$848K | ﹤0.01% | 2678 |
|
|
2021
Q4 | $1.48M | Buy |
9,521
+2,490
| +35% | +$388K | ﹤0.01% | 2929 |
|
|
2021
Q3 | $1.41M | Buy |
7,031
+775
| +12% | +$155K | ﹤0.01% | 2952 |
|
|
2021
Q2 | $1.6M | Buy |
6,256
+765
| +14% | +$196K | ﹤0.01% | 2932 |
|
|
2021
Q1 | $1.46M | Buy |
5,491
+1,884
| +52% | +$500K | ﹤0.01% | 2924 |
|
|
2020
Q4 | $1.33M | Buy |
3,607
+341
| +10% | +$126K | ﹤0.01% | 2912 |
|
|
2020
Q3 | $798K | Hold |
3,266
| – | – | ﹤0.01% | 2978 |
|
|
2020
Q2 | $941K | Buy |
3,266
+723
| +28% | +$208K | ﹤0.01% | 2954 |
|
|
2020
Q1 | $519K | Buy |
2,543
+1,593
| +168% | +$325K | ﹤0.01% | 3049 |
|
|
2019
Q4 | $424K | Buy |
950
+328
| +53% | +$146K | ﹤0.01% | 3157 |
|
|
2019
Q3 | $191K | Buy |
622
+1
| +0.2% | +$307 | ﹤0.01% | 3286 |
|
|
2019
Q2 | $198K | Hold |
621
| – | – | ﹤0.01% | 3324 |
|
|
2019
Q1 | $261K | Sell |
621
-604
| -49% | -$254K | ﹤0.01% | 3272 |
|
|
2018
Q4 | $373K | Buy |
1,225
+687
| +128% | +$209K | ﹤0.01% | 3192 |
|
|
2018
Q3 | $194K | Buy |
+538
| New | +$194K | ﹤0.01% | 3317 |
|